These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
113 related items for PubMed ID: 3721362
1. [General pharmacological action of tritoqualine (TRQ; (+/-)-(R*)-7-amino-4, 5, 6-triethoxy-3-[(R*)-5, 6, 7, 8-tetrahydro-4-methoxy-6-methyl-1, 3-dioxolo [4, 5-g] isoquinolin-5-yl] phthalide]. Narimatsu A, Nakao K, Egawa M, Hara H, Kitada Y, Yamazaki S, Miyake M, Tanaka T, Katayama S, Hashimoto N. Nihon Yakurigaku Zasshi; 1986 Apr; 87(4):457-78. PubMed ID: 3721362 [Abstract] [Full Text] [Related]
2. General pharmacology of recombinant human basic fibroblast growth factor. Okumura M, Yajima M, Nishimura T, Ikeda H, Nishimori T. Arzneimittelforschung; 1996 Jul; 46(7):727-39. PubMed ID: 8842346 [Abstract] [Full Text] [Related]
13. General pharmacology of the new non-xanthine adenosine A1 receptor antagonist (+)-(R)-[(E)-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)acryloyl]-2- piperidine ethanol. Terai T, Kusunoki T, Kita Y, Yoshida K, Akahane A, Shiokawa Y, Kohno Y, Horiai H, Mori J, Mine Y, Kohsaka M. Arzneimittelforschung; 1996 Feb; 46(2):185-91. PubMed ID: 8720311 [Abstract] [Full Text] [Related]
14. Pharmacological studies on timiperone, a new neuroleptic drug Part II: General pharmacological properties. Yamasaki T, Kojima H, Tanaka M, Aibara S, Hirohashi M, Kasai Y, Tsubokawa M, Watanabe K, Akashi A. Arzneimittelforschung; 1981 Feb; 31(4):707-15. PubMed ID: 6113834 [Abstract] [Full Text] [Related]
16. General pharmacological profiles of the new beta-adrenoceptor antagonist carvedilol. Hirohashi M, Takasuna K, Tamura K, Yamaguchi K, Maekawa K, Yamada S, Iwasaki S, Yoshida M, Nomura M, Taguchi K. Arzneimittelforschung; 1990 Jul; 40(7):735-46. PubMed ID: 1977393 [Abstract] [Full Text] [Related]
17. General pharmacological profile of the novel cholecystokinin-A antagonist loxiglumide. Saito T, Ukai K, Masuda T, Nakagawa T, Kimura K, Fujii M, Wakatsuki K, Saeki M, Kasai H. Arzneimittelforschung; 1997 Dec; 47(12):1375-82. PubMed ID: 9450167 [Abstract] [Full Text] [Related]
18. [General pharmacology of BMY-28100]. Goto A, Amano M, Sakai A, Hara M, Takahashi N. Jpn J Antibiot; 1990 Jul; 43(7):1289-309. PubMed ID: 2232158 [Abstract] [Full Text] [Related]
20. General pharmacological properties of the new angiotensin II receptor antagonist (+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate. Part I: Effects on central nervous system and other properties. Kito G, Morimoto S, Shiomi M. Arzneimittelforschung; 1996 Jun; 46(6):572-9. PubMed ID: 8767346 [Abstract] [Full Text] [Related] Page: [Next] [New Search]